Synthesis of fenarimols as novel drug candidates for Mycetoma
2020
- 42Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage42
- Abstract Views42
Artifact Description
Mycetoma, an infection caused by the Eumycetoma fungus, is a neglected tropical disease. This study was done in collaboration with OpenSource Mycetoma. The non-profit Open Source Mycetoma provided structures of molecules to synthesize based on their lead compound. The novel compounds were synthesized and later purified using techniques such as column chromatography. Using nuclear magnetic resonance (NMR) and thin layer chromatography (TLC), the compounds were characterized against the starting materials and other data to ensure the proper compound was synthesized. Confirmed molecules will be sent to our collaborators within the OpenSource Mycetoma organization for biological testing and will be shared with us to design new molecules. Three compounds have been successfully synthesized to date.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know